ISPOR

Conference Coverage

Closing the Gap Between Clinical Guideline Updates and Real-World Adoption for HER2-Low Therapies

06/17/2026

Jessica Paulus, ScD

Jessica Paulus, ScD, discusses the impact of education on increasing rates of human epidermal growth factor receptor 2 (HER2)-low therapy for patients with metastatic breast cancer.

Jessica Paulus, ScD, discusses...

06/17/2026

Journal of Clinical Pathways

Conference Coverage

Using Patient Characteristics and Treatment History to Inform Treatment Plans for Patients With Gene-Mutated MCRPC

06/15/2026

Andy Osterland, PharmD, MS

Andy Osterland, PharmD, MS, discusses a real-world study of patients with metastatic castration-resistant prostate cancer (MCRPC) who were treated with talazoparib plus enzalutamide and the regimen’s impact on homologous recombination repair...

Andy Osterland, PharmD, MS,...

06/15/2026

Journal of Clinical Pathways

Conference Coverage

Unlocking the Power of Mortality Data in Real-World Evidence: Overcoming Barriers and Driving Innovation

06/12/2026

Presenters at ISPOR 2026 demonstrated how integrating mortality data from multiple sources can substantially improve death ascertainment and strengthen the validity of real-world evidence for research and decision-making.

Presenters at ISPOR 2026...

06/12/2026

First Report Managed Care

Conference Coverage

The Enduring Challenge of Medical Device Identification: Is Artificial Intelligence Abstraction Ready for Broad Use and Acceptance?

06/12/2026

Experts at ISPOR 2026 explored how generative AI may overcome longstanding challenges in medical device identification, enabling more accurate and scalable real-world evidence generation from unstructured clinical data.

Experts at ISPOR 2026 explored...

06/12/2026

First Report Managed Care

Conference Coverage

Closing the Clinical Impact Evidence Gap: Practical RWE Strategies for Medical Devices and Diagnostics Using Registries, Research Partners, and Regulatory Data

06/12/2026

Experts at ISPOR 2026 highlighted how registries, linked data sources, and research collaborations can generate real-world evidence that bridges clinical evidence gaps for medical devices and diagnostics when traditional trials are not...

Experts at ISPOR 2026...

06/12/2026

First Report Managed Care

Conference Coverage

Listening at Scale: AI-Powered Insights into Systemic Lupus Erythematosus Patient Needs From Social Media

06/11/2026

Mitch DeKoven

Researchers found that AI-powered analysis of thousands of Reddit posts can identify unmet needs, symptom burdens, and care challenges among patients with systemic lupus erythematosus, highlighting the potential of social media listening to...

Researchers found that...

06/11/2026

First Report Managed Care

Conference Coverage

From Debate to Dialogue: Building Consensus on Prior Authorization Reform

06/11/2026

Mitch DeKoven

The growing use of prior authorization continues to create challenges for patients and providers, but experts at ISPOR 2026 outlined policy reforms and emerging AI-driven solutions that could improve transparency, efficiency, and access to...

The growing use of prior...

06/11/2026

First Report Managed Care

Conference Coverage

The Business of Evidence: HEOR for C-Suite Decision Making

06/11/2026

Mitch DeKoven

A forum at ISPOR 2026 highlighted how HEOR leaders can drive organizational growth by translating complex value evidence into strategic insights that resonate with C-suite priorities.

A forum at ISPOR 2026...

06/11/2026

First Report Managed Care

Conference Coverage

Closing the Gap in HRR Testing for Metastatic Prostate Cancer in Community Oncology

06/04/2026

Helen Latimer, MPH

Helen Latimer, MPH, discusses new real-world evidence showing increased homologous recombination repair (HRR) genetic testing among patients with metastatic prostate cancer and the potential of electronic health record (HER)-driven clinical...

Helen Latimer, MPH, discusses...

06/04/2026

Journal of Clinical Pathways

ISPOR

HMP Global Products

Events